Home › Bronchiolitis Obliterans Syndrome › Florida
Bronchiolitis Obliterans Syndrome clinical trials in Florida
14 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in Florida.
Cities in Florida
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
- Moffitt Cancer Center, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07011810An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Bowden Eye Associates - Southside Location, Jacksonville
- University of Miami, Miller School of Medicine, Bascom Palmer Eye Institute, Miami
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Sep 21, 2026 · NCT07395232Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
- Moffitt Cancer Center, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05996627A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Miami Cancer Institute, Miami
- Orlando Health Cancer Institute Downtown Orlando, Orlando
- Memorial Cancer Institute, Pembroke Pines
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Adventhealth Pediatric Cellular Therapy and Blood and Marrow Transplant, Orlando
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Sep 15, 2026 · NCT07124078Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Mayo Clinic Jacksonville, Jacksonville
- AdventHealth Orlando, Orlando
- Moffit Cancer Center, Orlando
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
- Univ of Miami - Sylvester Comprehensive Cancer Center, Miami
- Moffitt Cancer Center, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06660355Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
- University of Miami, Miami
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jun 22, 2026 · NCT06663722A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- University of Miami, Miami
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Miami, Miami
- Moffitt Cancer Center, Tampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
- University of South Florida, Tampa
Recruiting
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT06464926A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- AdventHealth Orlando, Orlando
- Moffitt Cancer Center, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation
- Ambulatory Care Center, Florida International University, Miami
Recruiting
Ages 19 to 80 · All sexes · Updated Sep 30, 2025 · NCT07199361Freedom-1 Study for Chronic Knee Pain
- Holy Cross Hospital, Inc, Fort Lauderdale
- Florida Joint Care Institute, Trinity
Recruiting
Ages 18 and older · All sexes · Updated Feb 13, 2025 · NCT03877653From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.